Inhaled corticosteroids: past lessons and future issues.

[1]  I. Reid,et al.  Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients , 1992, Osteoporosis International.

[2]  Hartmut Derendorf,et al.  Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives , 1999, Pharmaceutical Research.

[3]  M. Detmar,et al.  Corticosteroids induce proliferation but do not influence TNF- or IL-1Β-induced ICAM-1 expression of human dermal microvascular endothelial cells in vitro , 2004, Archives of Dermatological Research.

[4]  S. Rohatagi,et al.  Ciclesonide, a novel inhaled steroid, has no effect on hypothalamic-pituitary-adrenal (HPA)-axis function in mild-to-moderate asthmatics* , 2003 .

[5]  S. Szefler,et al.  High doses of the novel inhaled steroid ciclesonide have no effect on HPA-axis function in patients with moderate-to-severe persistent asthma , 2003 .

[6]  D. Allen,et al.  Inhaled corticosteroids, growth, and compliance. , 2002, The New England journal of medicine.

[7]  U. Wahn,et al.  Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. , 2002, Pediatrics.

[8]  Stephen C Lazarus,et al.  Systemic effect comparisons of six inhaled corticosteroid preparations. , 2002, American journal of respiratory and critical care medicine.

[9]  U. Schneyer,et al.  Delay of growth and development in children with bronchial asthma, atopic dermatitis and allergic rhinitis. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[10]  A. Galanos,et al.  A Randomized Trial of Nasal Spray Salmon Calcitonin in Men With Idiopathic Osteoporosis: Effects on Bone Mineral Density and Bone Markers , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Stephen C Lazarus,et al.  Banks CORTICOSTEROIDS FOR PERSISTENT ASTHMA SIGNIFICANT VARIABILITY IN RESPONSE TO INHALED Services , 2022 .

[12]  D. Allen.  Inhaled corticosteroid therapy for asthma in preschool children: growth issues. , 2002, Pediatrics.

[13]  E. Siegfried,et al.  Stevens–Johnson Syndrome Developing in a Girl with Systemic Lupus Erythematosus on High‐Dose Corticosteroid Therapy , 2002, Pediatric dermatology.

[14]  Lester R Curtin,et al.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. , 2002, Pediatrics.

[15]  D. N. Kolbach,et al.  Tinea incognito due to Trichophytom rubrum after local steroid therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  G. Piérard,et al.  Comparative effect of hormone replacement therapy on bone mass density and skin tensile properties. , 2001, Maturitas.

[17]  J. Souberbielle,et al.  DHEA in bone and joint diseases. , 2001, Joint, bone, spine : revue du rhumatisme.

[18]  A. Boner,et al.  Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. , 2001, Archives of pediatrics & adolescent medicine.

[19]  E. Dursun,et al.  COMPARISON OF ALENDRONATE, CALCITONIN AND CALCIUM TREATMENTS IN POSTMENOPAUSAL OSTEOPOROSIS , 2001, International journal of clinical practice.

[20]  U. Schlötzer-Schrehardt,et al.  Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. , 2001, Investigative ophthalmology & visual science.

[21]  G. Fitzmaurice,et al.  Effects of inhaled glucocorticoids on bone density in premenopausal women. , 2001, The New England journal of medicine.

[22]  P. Murray,et al.  Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. , 2001, Investigative ophthalmology & visual science.

[23]  A. Jobling,et al.  Binding of Dexamethasone by α-Crystallin , 2001 .

[24]  A. Jobling,et al.  Is there a glucocorticoid receptor in the bovine lens? , 2001, Experimental eye research.

[25]  P. Daley-Yates,et al.  Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. , 2001, British journal of clinical pharmacology.

[26]  G. Town,et al.  Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years , 2001, Thorax.

[27]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[28]  W. Busse,et al.  Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. , 2000, The Journal of allergy and clinical immunology.

[29]  A. Laties,et al.  Association between intraocular pressure and budesonide inhalation therapy in asthmatic patients. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[30]  N Franklin Adkinson,et al.  Long-term effects of budesonide or nedocromil in children with asthma. , 2000, The New England journal of medicine.

[31]  S. Pedersen,et al.  Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. , 2000, The New England journal of medicine.

[32]  K. Carlsen,et al.  Asthma drug adherence in a long term clinical trial , 2000, Archives of disease in childhood.

[33]  E. Orwoll,et al.  Alendronate for the treatment of osteoporosis in men. , 2000, The New England journal of medicine.

[34]  S. Suissa,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[35]  J. Honour,et al.  Inhaled corticosteroids and the hypothalamic-pituitary-adrenal (HPA) axis: do we understand their interaction? , 2000, Respiratory medicine.

[36]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2000 .

[37]  P. Pasqualetti,et al.  Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup. , 2000, Ophthalmology.

[38]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[39]  R. Hubbard,et al.  Inhaled corticosteroid use and bone-mineral density in patients with asthma , 2000, The Lancet.

[40]  W. Scherer,et al.  Effect of Latanoprost on Intraocular Pressure in Steroid‐induced Glaucoma , 2000, Journal of glaucoma.

[41]  R. Patterson,et al.  Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. , 2000, Allergy and asthma proceedings.

[42]  R. Voutilainen,et al.  Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. , 2000, The Journal of clinical endocrinology and metabolism.

[43]  P. Daley-Yates,et al.  Systemic Exposure to Fluticasone Propionate Administered via Metered-Dose Inhaler Containing Chlorofluorocarbon or Hydrofluoroalkane Propellant , 2000, Clinical pharmacokinetics.

[44]  T. Hartert,et al.  Epidemiology of asthma: the year in review. , 2000, Current opinion in pulmonary medicine.

[45]  Kelly Hw.  Comparative potency and clinical efficacy of inhaled corticosteroids. , 1999 .

[46]  S. Parapuram,et al.  Corticosteroids and Glaucoma Risk , 1999, Drugs & aging.

[47]  S. Pedersen,et al.  Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. , 1999, The Journal of allergy and clinical immunology.

[48]  J. Salvemini,et al.  Perioral dermatitis in children. , 1999, Seminars in cutaneous medicine and surgery.

[49]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[50]  Y. Buys,et al.  Glaucoma secondary to topical use of steroid cream. , 1999, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[51]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[52]  B. Lipworth.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. , 1999, Archives of internal medicine.

[53]  J. Warner,et al.  Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone. , 1999, The European respiratory journal.

[54]  R. Cumming,et al.  Inhaled Corticosteroids and Cataract , 1999, Drug safety.

[55]  G. Kollerup,et al.  Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. , 1998, The Journal of pediatrics.

[56]  S. Suissa,et al.  Association of inhaled corticosteroid use with cataract extraction in elderly patients. , 1998, JAMA.

[57]  Jacques P. Brown,et al.  Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .

[58]  M. Dahlbäck,et al.  Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue. , 1998, Drug metabolism and disposition: the biological fate of chemicals.

[59]  W. Storms,et al.  Clinical Effects of Inhaled Corticosteroids: Results of a Questionnaire Survey of Asthma Specialists , 1998 .

[60]  E. Shane,et al.  Osteoporosis after Organ Transplantation * * Access the Journal Club discussion of this paper at: , 1998 .

[61]  D. Mannino,et al.  Surveillance for asthma--United States, 1960-1995. , 1998, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[62]  B. Meibohm,et al.  Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. , 1998, The Journal of allergy and clinical immunology.

[63]  P. Paggiaro,et al.  Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.

[64]  R. Nathan,et al.  Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. , 1998, The Journal of pediatrics.

[65]  L. Boulet.  Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. , 1998, Chest.

[66]  C. Christiansen,et al.  Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. , 1998 .

[67]  J. Risteli,et al.  Effects of long-term inhaled corticosteroids on skin collagen synthesis and thickness in asthmatic patients. , 1998, The European respiratory journal.

[68]  J. Paulson,et al.  Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. , 2003, British journal of clinical pharmacology.

[69]  F. Simons,et al.  A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. , 1997, The New England journal of medicine.

[70]  H. Derendorf.  Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. , 1997, Respiratory medicine.

[71]  A. Tunek,et al.  Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[72]  G. Kollerup,et al.  Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide , 1997, Steroids.

[73]  B. Lipworth,et al.  Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children. , 1997, Thorax.

[74]  R. Cumming,et al.  Use of inhaled corticosteroids and the risk of cataracts. , 1997, The New England journal of medicine.

[75]  A. Casalini,et al.  Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. , 1997, American journal of respiratory and critical care medicine.

[76]  C E Reed,et al.  Attained adult height after childhood asthma: effect of glucocorticoid therapy. , 1997, The Journal of allergy and clinical immunology.

[77]  C. Mcevoy,et al.  Adverse effects of corticosteroid therapy for COPD. A critical review. , 1997, Chest.

[78]  J. Polansky,et al.  Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. , 1997, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[79]  R. Roorda,et al.  One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. , 1997, American journal of respiratory and critical care medicine.

[80]  A. Bye,et al.  Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. , 2003, British journal of clinical pharmacology.

[81]  C. Rand,et al.  Noncompliance and treatment failure in children with asthma. , 1996, The Journal of allergy and clinical immunology.

[82]  A Bye,et al.  Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate , 1996, Journal of clinical pharmacology.

[83]  T. Hamilton,et al.  Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid‐induced epidermal atrophy , 1996, The British journal of dermatology.

[84]  P. Autio,et al.  Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo. , 1996, American journal of respiratory and critical care medicine.

[85]  L. Paquette,et al.  Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function. , 1996, The European respiratory journal.

[86]  G. Russell,et al.  Posterior subcapsular cataract and inhaled corticosteroid therapy. , 1995, Thorax.

[87]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis. , 1994, Rheumatic diseases clinics of North America.

[88]  M. Kaiser-Kupfer,et al.  Posterior subcapsular cataract in endogenous Cushing syndrome: an uncommon manifestation. , 1993, Investigative ophthalmology & visual science.

[89]  W. O'Fallon,et al.  Long‐term fracture prediction by bone mineral assessed at different skeletal sites , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[90]  M. Cheang,et al.  Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids , 1993, The Lancet.

[91]  S. Pedersen,et al.  Short‐term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids , 1993, Acta paediatrica.

[92]  K. Offord,et al.  Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. , 1993, Pediatrics.

[93]  S. Pedersen,et al.  Importance of the inhalation device on the effect of budesonide. , 1993, Archives of disease in childhood.

[94]  H. V. van Houwelingen,et al.  Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. , 1993, Pediatrics.

[95]  C. van Weel,et al.  Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective Study , 1993, Annals of Internal Medicine.

[96]  S. Pedersen,et al.  Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate. , 1993, Archives of disease in childhood.

[97]  E. Shane,et al.  Osteoporosis after cardiac transplantation. , 1993, The American journal of medicine.

[98]  J. Baskerville,et al.  Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma. , 1993, The Journal of allergy and clinical immunology.

[99]  R. Aggarwal,et al.  Extensive visual loss with topical facial steroids , 1993, Eye.

[100]  S. Spiro,et al.  Easy bruising as a side-effect of inhaled corticosteroids. , 1992, The European respiratory journal.

[101]  J. Douglas,et al.  Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. , 1992, Thorax.

[102]  G. Russell,et al.  Asthma, inhaled corticosteroid treatment, and growth. , 1992, Archives of disease in childhood.

[103]  S. Pedersen,et al.  Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. , 1992, Pediatrics.

[104]  S. Shevell,et al.  Ocular toxicity of prednisone in pediatric patients with inflammatory bowel disease. , 1992, Lens and eye toxicity research.

[105]  C. Mackenzie,et al.  Growth of Asthmatic-Children , 1991 .

[106]  S. Pedersen,et al.  Growth of asthmatic children during treatment with budesonide: a double blind trial. , 1991, BMJ.

[107]  J. Lévêque,et al.  Reversal effects of topical retinoic acid on the skin of kidney transplant recipients under systemic corticotherapy. , 1990, The Journal of investigative dermatology.

[108]  S. Pedersen,et al.  Short term linear growth in asthmatic children during treatment with prednisolone. , 1990, BMJ.

[109]  S. Capewell,et al.  Purpura and dermal thinning associated with high dose inhaled corticosteroids. , 1990, BMJ.

[110]  J. Jonas,et al.  [Glaucoma in central hypothalamic-hypophyseal Cushing syndrome]. , 1990, Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[111]  L. Kligman,et al.  Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect. , 1989, Journal of the American Academy of Dermatology.

[112]  D. Lubach,et al.  Steroid-Induced Dermal Atrophy , 1989 .

[113]  E. Berardesca,et al.  Skin extensibility time in women. Changes in relation to sex hormones. , 1989, Acta dermato-venereologica.

[114]  J. Tanner,et al.  Clinical longitudinal standards for height and height velocity for North American children. , 1985, The Journal of pediatrics.

[115]  M. Clement,et al.  Is Steroid tachyphylaxis preventable? , 1985, Clinical and experimental dermatology.

[116]  A. Adinoff,et al.  Steroid-induced fractures and bone loss in patients with asthma. , 1983, The New England journal of medicine.

[117]  R. Lavker,et al.  Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy. , 1983, The Journal of investigative dermatology.

[118]  L. Landau,et al.  THE EFFECT ON GROWTH OF CHILDHOOD ASTHMA , 1981, Acta paediatrica Scandinavica.

[119]  T. Amemiya,et al.  Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract. , 1980, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[120]  A. Vivier.  Tachyphylaxis to Topically Applied Steroids , 1976 .

[121]  R. Wehr,et al.  Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats. , 1976, Archives of dermatology.

[122]  J L Burton,et al.  A rapid increase in skin extensibility due to prednisolone , 1973, The British journal of dermatology.